Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation - Wikidata - awgldk - TriplyDB

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

http://www.wikidata.org/entity/Q28088625

about

Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.Botulinum toxin injection for contouring shoulder.Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions.Beyond the muscular effects - onabotulinumtoxinA injections for pain control in chronic knee osteoarthritis: a case report

P2860

Q48234656-1CD95A95-3E8F-4E37-82C9-729B9CE9DA22 Q51520833-D321DB32-966C-4EEA-860A-BBCC30703995 Q52609601-3EA4A90E-C763-4A8F-8DB3-1436827DE8D2 Q57071292-56C3BC48-306B-4814-BB61-43BE23E3BBB4

P2860

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

http://www.wikidata.org/entity/Q28088625

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@ast

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@en

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@nl

type

label

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@ast

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@en

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@nl

prefLabel

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@ast

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@en

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@nl

P1433

Q28088625-422D6394-63CE-4AD2-942D-29497F932DDC

P1476

Q28088625-E34CC534-5D5B-48FD-8CC6-02D300221286

P2093

Q28088625-4F374D5E-803E-45E3-BFD6-C270A7329CEF

Q28088625-94F2DCA8-2AD0-409E-87B3-2EBD03822570

Q28088625-A8DB4A9B-9C8F-40DA-B891-C273A1E76246

Q28088625-DF9D9362-75EE-4D56-A30D-927FE2AE9C0B

Q28088625-EAF6E327-8EEA-44E4-8DB1-C093AE634B0A

P275

Q28088625-6CB9F6FE-9BBC-48C2-8E16-5FA5EAF1074A

P2860

Q28088625-05188A72-E109-4C18-A8F8-69C248DFD8E8

Q28088625-07716690-986E-4E9B-B7B9-B3BA45BA86DA

Q28088625-0B737BFD-860B-467F-8603-21D377FC0EC6

Q28088625-0BD13CE1-D729-4A66-A226-660AF4B33D10

Q28088625-0DD1D07E-948A-4762-A13C-5BEC91D7A9D7

Q28088625-0E966431-B436-4029-98E9-B16B47B758B7

Q28088625-1882B3D6-81E0-4B66-AB88-6317828F2566

Q28088625-192C7928-64EE-4734-BF20-0F037930F4F1

Q28088625-239E4135-FDA8-467D-8B72-C669B94F894B

Q28088625-249C6382-FB2C-4467-AD2F-650B36B4EE68

P304

Q28088625-3EF944A7-1635-4967-8BA7-BEEF4939BEC9

P31

Q28088625-0E4414EB-6B84-4C28-9AA1-76A5E4E73697

Q28088625-21F8B328-D31E-4D20-9627-A3CA141C1B78

P356

Q28088625-A6A6C4EE-0283-4A30-90E0-B3F89C3AAD3F

P407

Q28088625-E499A6FC-A1D3-4896-AE7F-9340896BC4CC

P433

Q28088625-80628D17-BEDE-4929-878C-1F20F380FC3F

P478

Q28088625-1AA42269-3F18-4D10-A0CA-F29246FD5AAC

P5008

Q28088625-FA30886C-EF7C-4669-AAEB-11A59B83FA6C

P577

Q28088625-CC0768BC-EEA8-45F5-BA26-4ACD5E01FB4E

P5875

Q28088625-442B7EA2-351A-46D1-9060-E8B2B6938416

P698

Q28088625-B3B328F5-A584-4EC1-837B-C6647DDB7258

P921

Q28088625-42B089E8-E798-4859-803E-92375D44A3B3

Q28088625-4D654228-A65B-4389-B979-645A20815325

Q28088625-9EADEA5D-F49B-48CB-9468-B57F75EFF78C

P932

Q28088625-B0D0B235-BD38-4A2A-9DDD-FC6E9E7D61B3

P356

P1433

P1476

Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation

@en

P2093

Andrea Santamato

http://www.w3.org/2001/XMLSchema#string

Domenico Intiso

http://www.w3.org/2001/XMLSchema#string

Filomena Di Rienzo

http://www.w3.org/2001/XMLSchema#string

Mario Basciani

http://www.w3.org/2001/XMLSchema#string

Marta Intiso

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Botulinum toxin for myofascial pain syndromes in adults

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Molecular mechanisms of nociception

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

Effects of strengthening, stretching and functional training on foot function in patients with diabetic neuropathy: results of a randomized controlled trial.

Clinical features and pathophysiology of complex regional pain syndrome.

Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.

P304

2454-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXINS7072454

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280623805

http://www.w3.org/2001/XMLSchema#string

P698

26134256

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

bacterial protein

P932

4516923

http://www.w3.org/2001/XMLSchema#string